Effective as of February 28, 2024, the board of directors of IR-Med Inc. appointed Mr. Aharon Klein, Chief Technology Officer and a co-founder of the company to serve as its Interim Chief Executive Officer as well as the Interim Chief Executive Officer of the company?s wholly-owned subsidiary, IR-Med LTD. Mr. Aharon Klein, age 60, co-founded IR. Med Ltd. in September 2013 and has served as a director of the Company since. He also served as the Company?s Chief Operating Officer from September 2013 until December 2020.

Since December 2020, Mr. Klein serves as the Company?s Chief Technology Officer. Mr. Klein is a medical device and biotech expert, with a strong clinical background. Prior to founding the Company, from 2004 to 2007 Mr. Klein co-founded and served as Chief Executive Officer of Fertiligent.

From 2008 to 2013, immediately prior to co-founding of the Company, he founded a medical device company developing infrared based diagnostic tools for diagnosing colon cancer without the need for biopsies (optical biopsies). Mr. Klein graduated from the Faculty of Engineering in the Technion - Israel Institute of Technology. Mr. Klein is experienced in initiating and running medical device start-up companies, including development running clinical trials and regulatory affairs.